The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer

Despite the recent development of precision medicine and targeted therapies, lung cancer remains the top cause of cancer-related mortality worldwide. The patients diagnosed with metastatic disease have a five-year survival rate lower than 6%. In metastatic disease, EGFR is the most common driver of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fregni, Matilde, Ciribilli, Yari, Zawacka-Pankau, Joanna E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267050/
https://www.ncbi.nlm.nih.gov/pubmed/35806218
http://dx.doi.org/10.3390/ijms23137213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267050/
https://www.ncbi.nlm.nih.gov/pubmed/35806218
http://dx.doi.org/10.3390/ijms23137213

Ejemplares similares